InSitu Biologics, Inc.
PrivateLast Round
Seed Round
Aug 4, 2026
Est. Valuation
$34M
Total Funding Raised
$10M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
InSitu Biologics, Inc. operates in Healthcare & Life Sciences and is based in Oakdale, Minnesota. Its latest recorded funding round was a Series A round in December 2021.
InSitu Biologics, Inc. is a biotechnology company that develops a multi-phase prolonged-release drug delivery platform for the localized treatment of pain, cancer, and infection.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
InSitu Biologics, Inc. Comparables
Compare InSitu Biologics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AmacaThera | 88% | |
| Sustained Therapeutics | 85% | |
| Allay Therapeutics | 85% |
For institutional investors. Book with your work email.
InSitu Biologics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Aug 4, 2026 | ||||
| Early Funding | Nov 13, 2025 | ||||
| Series A | Dec 28, 2021 | ||||
| Corporate Funding | Jul 31, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 4, 2026
$1.25M seed round completed.
- Jul 24, 2026
Monthly visitors increased 59% MoM.
For institutional investors. Book with your work email.
InSitu Biologics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about InSitu Biologics, Inc.'s valuation, stock price, and market status.
Is InSitu Biologics, Inc. a public or private company?
InSitu Biologics, Inc. is a private company.
What is the current stock price of InSitu Biologics, Inc.?
InSitu Biologics, Inc. is a private company, so its shares have no public market price. Caplight tracks InSitu Biologics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is InSitu Biologics, Inc. worth (valuation)?
InSitu Biologics, Inc.'s valuation is estimated at $34.0M based on funding round data.
Can I buy InSitu Biologics, Inc. stock?
InSitu Biologics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was InSitu Biologics, Inc.'s last funding round?
InSitu Biologics, Inc.'s most recent funding round was Seed Round on August 4, 2026.
Who are the main investors in InSitu Biologics, Inc.?
Investor information for InSitu Biologics, Inc. is not publicly disclosed.
Will InSitu Biologics, Inc. IPO soon?
No public IPO plans have been announced for InSitu Biologics, Inc..
How can I track InSitu Biologics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in InSitu Biologics, Inc.'s shares on secondary markets.